Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

BACKGROUND: RBM3 expression has been suggested as prognostic marker in several cancer types. The purpose of this study was to assess the prevalence and clinical significance of altered RBM3 expression in esophageal cancer. METHODS: RBM3 protein expression was measured by immunohistochemistry using t...

Descripción completa

Detalles Bibliográficos
Autores principales: Grupp, Katharina, Hofmann, Bianca, Kutup, Asad, Bachmann, Kai, Bogoevski, Dean, Melling, Nathaniel, Uzunoglu, Faik Guntac, El Gammal, Alexander Tarek, Koop, Christina, Simon, Ronald, Steurer, Stefan, Krech, Till, Burdak-Rothkamm, Susanne, Jacobsen, Frank, Sauter, Guido, Izbicki, Jakob, Wilczak, Waldemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233549/
https://www.ncbi.nlm.nih.gov/pubmed/30419865
http://dx.doi.org/10.1186/s12885-018-5032-z

Ejemplares similares

Ejemplares similares